Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Endotoxin Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Burnett, R.J.
Right arrow Articles by Solomkin, J.S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Burnett, R.J.
Right arrow Articles by Solomkin, J.S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effects of bactericidal/permeability-increasing protein upon mononuclear cell interactions with endotoxin: evidence for cell binding

R.J. Burnett

Department of Surgery, Universit), of Cincinnati, Cincinnati, Ohio, Incyte Pharmaceuticals Inc., Palo Alto, California, Shriner's Burns Institute, Cincinnati, Ohio, USA

C.A. Lyden

Department of Surgery, Universit), of Cincinnati, Cincinnati, Ohio, Incyte Pharmaceuticals Inc., Palo Alto, California, Shriner's Burns Institute, Cincinnati, Ohio, USA

C.J. Tindal

Department of Surgery, Universit), of Cincinnati, Cincinnati, Ohio, Incyte Pharmaceuticals Inc., Palo Alto, California, Shriner's Burns Institute, Cincinnati, Ohio, USA

M.N. Marra

Department of Surgery, Universit), of Cincinnati, Cincinnati, Ohio, Incyte Pharmaceuticals Inc., Palo Alto, California, Shriner's Burns Institute, Cincinnati, Ohio, USA

A.N. Neely

Department of Surgery, Universit), of Cincinnati, Cincinnati, Ohio, Incyte Pharmaceuticals Inc., Palo Alto, California, Shriner's Burns Institute, Cincinnati, Ohio, USA

J.S. Solomkin

Department of Surgery, Universit), of Cincinnati, Cincinnati, Ohio, Incyte Pharmaceuticals Inc., Palo Alto, California, Shriner's Burns Institute, Cincinnati, Ohio, USA

Because of the mortality associated with Gram-negative infections, there is interest in the mechanisms by which bacterial endotoxin is processed by leukocytes. Several lipid A binding proteins, including lipopolysaccharide-binding protein (LBP) and bactericidal/permeability-increasing protein (BPI), mediate the process of LPS activity. Our studies show that BPI was capable of mediating the binding of tritiated LPS to the mononuclear cell line THP-1 in a fashion not affected by the addition of an anti-CD14 antibody, and that such binding did not elicit a TNFa response. Soluble BPI was capable of competing with LBP for LPS and inhibiting the TNF{alpha} response associated with LBP-LPS stimulation. In addition, cells pretreated with BPI and then washed were then capable of binding significantly more LPS than controls. These pretreated cells were also capable of inhibiting TNF{alpha} production to subsequent LBP-LPS. Western blotting confirmed the uptake of BPI to THP-1 cells both with and without LPS. We conclude that BPI is capable of interacting with THP-1 cells in the free form or complexed to LPS, without eliciting a TNF{alpha} response. Cells exposed to BPI are resistant to subsequent stimulation with LBP-LPS, thereby suggesting a novel mechanism for the anti-inflammatory effects of BPI.

Journal of Endotoxin Research, Vol. 2, No. 5, 349-357 (1995)
DOI: 10.1177/096805199500200505


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?